SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (993)3/1/2002 11:25:27 AM
From: keokalani'nui  Read Replies (2) of 2243
 
Re: ASCO and some shallow comments about onyx.

With confirmation that x015 takes a back seat, this:

>>Clinical trials for BAY 43-9006 started in 2000. To date, data have been presented showing encouraging results at modest doses during the dose-escalation portion of the Phase I studies. Specifically, side effects like skin rashes and diarrhea were observed and there was biochemical evidence supporting the mechanistic approach. Several abstracts have been submitted to ASCO 2002 which will provide additional clinical data. We are excited by the Phase I data we have seen to date. We are increasing investment to support a comprehensive Phase II program targeting a range of tumors treating patients with BAY 43-9006 alone and in combination with chemotherapy.<<

One might be thinking onyx is assuring exciting asco results and one might be tempted to think this is a trading buy for a pre-presentation. But, this is a faint-praise way of calling attention to 43-9006 and maybe data is really only equivocal at this stage, or else why would it not already have roared to the front? Problems with x015 have been evident for a long time. Also, describing 43-9006 as a financing candidate instead of praising its promising anti-cancer attributes is weird. Finally, to mention but not distinguish between Gleevec and Herceptin and then not to state where its drug fits in is also suspicious.

I warned they were shallow comments.

Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News